LGNZZ LIGAND PHARMACEUTICALS INC | 886163
Available Fillings
Total Fillings:2114
| Form Type | Form Count |
|---|---|
| 8-K | 430 |
| UPLOAD | 29 |
| NT 10-Q | 7 |
| NT 10-K | 2 |
| S-8 | 18 |
| 10-Q | 85 |
| CORRESP | 29 |
| S-3/A | 7 |
| SC 13E4 | 1 |
| 424B1 | 1 |
| PREM14A | 1 |
| 8-A12B | 1 |
| CT ORDER | 44 |
| SC 13D/A | 39 |
| SC 13D | 12 |
| 425 | 47 |
| 3/A | 3 |
| 144/A | 1 |
| POS AM | 6 |
| SC 13G | 64 |
| 8-K/A | 17 |
| SC TO-T/A | 3 |
| S-4 | 4 |
| 10-K | 27 |
| 4/A | 36 |
| ARS | 4 |
| S-1/A | 4 |
| PREN14A | 1 |
| 5 | 2 |
| 8-A12G/A | 3 |
| SC TO-C | 2 |
| 15-12G | 1 |
| SC 13E3 | 1 |
| 144 | 27 |
| SC 13G/A | 136 |
| DEFA14A | 18 |
| 424B3 | 33 |
| 424B5 | 2 |
| DEFM14A | 1 |
| 4 | 837 |
| 3 | 40 |
| DEF 14A | 29 |
| S-3ASR | 3 |
| S-1 | 2 |
| DFAN14A | 1 |
| 10-Q/A | 12 |
| 10-K/A | 6 |
| EFFECT | 5 |
| S-4/A | 3 |
| SC 13E3/A | 1 |
| 8-A12G | 1 |
| PRER14A | 3 |
| SCHEDULE 13G/A | 3 |
| DEFN14A | 2 |
| PRE 14A | 4 |
| SC TO-T | 1 |
| S-3 | 8 |
| S-8 POS | 2 |
| SC 13E4/A | 1 |
| D | 1 |
Financials
Total:577
Ipos
Total:68
Insider transactions
Total:918
Institutional filings
Total:105
Merger acquisition
Total:483
Proxy filings
Total:33